Home > Riviste > Minerva Biotecnologica > Fascicoli precedenti > Minerva Biotecnologica 2002 June;14(2) > Minerva Biotecnologica 2002 June;14(2):143-8

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi PROMO
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Estratti
Permessi

 

REVIEWS  7th INTERNATIONAL CONFERENCE ON TRANSGLUTAMINASES AND PROTEIN CROSSLINKING REACTIONS
Ferrara (Italy), September 14-17, 2002
 

Minerva Biotecnologica 2002 June;14(2):143-8

Copyright © 2003 EDIZIONI MINERVA MEDICA

lingua: Inglese

The biotechnological applications of transglutaminases

Collighan R., Cortez J., Griffin M.

Department of Life Sciences, The Nottingham Trent University, Nottingham, UK


PDF


Trans­glu­ta­mi­nas­es cat­a­lyse a ­diverse ­range of reac­tions lead­ing to the mod­ifi­ca­tion of pro­teins and pep­tides ­such ­that ­their phys­i­cal, chem­i­cal and bio­log­i­cal prop­er­ties ­become ­changed. ­They are ­found in ­many dif­fer­ent liv­ing organ­isms and as a con­se­quence dis­play sub­tle dif­fer­enc­es in ­their bio­chem­i­cal and phys­i­cal prop­er­ties. It is there­fore not sur­pris­ing ­that ­this ­group of ­enzymes ­have ­been exploit­ed as ­applied bio­cat­a­lysts in a ­wide ­range of com­mer­cial sec­tors var­y­ing ­from the tex­tile indus­try to the high­ly lucra­tive cos­met­ic indus­try. In addi­tion the path­o­phy­sio­log­i­cal impor­tance of ­this ­group of ­enzymes has ­increased sig­nif­i­cant­ly ­over the ­last ­decade ­with ­their involve­ment not­ed in a num­ber of ­human dis­eas­es. As a con­se­quence ­their iden­tifi­ca­tion as ther­a­peu­tic tar­gets or as mon­i­tor­ing ­aids for a ­range of dif­fer­ent dis­eas­es has ­caused sig­nif­i­cant inter­est ­from the diag­nos­tics and phar­ma­ceu­ti­cal indus­tries. ­This ­review ­describes ­some of the cur­rent appli­ca­tions of trans­glu­ta­mi­nas­es togeth­er ­with ­their poten­tial stra­te­gic impor­tance and ­future ­uses.

inizio pagina